Unfortunately, resistance to platinum-based chemotherapy can develop over time. This is a significant challenge, particularly in recurrent ovarian cancer. Researchers are actively working on understanding the mechanisms of resistance to develop new strategies to overcome it. Combination therapies and personalized treatment plans are some approaches being investigated.
